Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Spendlove

Showing results (11-20 of 24) with videos related to

Pageof 3
Sort By:
International Journal of Cancer|April 6, 2001
Human anti-idiotypic antibodies can be good immunogens as they target FC receptors on antigen-presenting cells allowing efficient stimulation of both helper and cytotoxic T-cell responsesL G Durrant, T Parsons, R Moss, et al.
Lancet (London, England)|August 25, 1990
Dementia with beta-amyloid deposition: involvement of alpha B-crystallin supports two main diseasesJ Lowe, M Landon, I Pike, et al.
Vaccine|August 17, 2004
A novel CEA vaccine stimulates T cell proliferation, gammaIFN secretion and CEA specific CTL responsesT Parsons, I Spendlove, R Nirula, et al.
Mabs|January 5, 2010
Antibodies designed as effective cancer vaccinesR L Metheringham, V A Pudney, B Gunn, et al.
Neuropathology and Applied Neurobiology|August 1, 1992
Ballooned neurons in several neurodegenerative diseases and stroke contain alpha B crystallinJ Lowe, D R Errington, G Lennox, et al.
British Journal of Cancer|March 15, 2012
The chemokine, CXCL12, is an independent predictor of poor survival in ovarian cancerA Popple, L G Durrant, I Spendlove, et al.
Clinical Immunology (Orlando, Fla.)|May 30, 2008
T-cell responses in osteosarcoma patients vaccinated with an anti-idiotypic antibody, 105AD7, mimicking CD55G J Ullenhag, I Spendlove, N F S Watson, et al.
The Journal of Pathology|November 1, 1992
Production and characterization of a polyclonal antibody to the c-erbB-3 protein: examination of c-erbB-3 protein expression in adenocarcinomasD N Poller, I Spendlove, C Baker, et al.
Cancer Immunology, Immunotherapy : CII|June 18, 2003
Enhanced expression of the complement regulatory protein CD55 predicts a poor prognosis in colorectal cancer patientsL G Durrant, M A Chapman, D J Buckley, et al.
Molecular Pathology : MP|July 13, 2000
Characterisation of a mouse monoclonal anti-idiotype reactive with a V region sequence commonly used by human immunoglobulinsJ E McElveen, P B Furtado, S J Smith, et al.
Pageof 3

Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
International Journal of Cancer|April 6, 2001
Human anti-idiotypic antibodies can be good immunogens as they target FC receptors on antigen-presenting cells allowing efficient stimulation of both helper and cytotoxic T-cell responsesL G Durrant, T Parsons, R Moss, et al.
Lancet (London, England)|August 25, 1990
Dementia with beta-amyloid deposition: involvement of alpha B-crystallin supports two main diseasesJ Lowe, M Landon, I Pike, et al.
Vaccine|August 17, 2004
A novel CEA vaccine stimulates T cell proliferation, gammaIFN secretion and CEA specific CTL responsesT Parsons, I Spendlove, R Nirula, et al.
Mabs|January 5, 2010
Antibodies designed as effective cancer vaccinesR L Metheringham, V A Pudney, B Gunn, et al.
Neuropathology and Applied Neurobiology|August 1, 1992
Ballooned neurons in several neurodegenerative diseases and stroke contain alpha B crystallinJ Lowe, D R Errington, G Lennox, et al.
British Journal of Cancer|March 15, 2012
The chemokine, CXCL12, is an independent predictor of poor survival in ovarian cancerA Popple, L G Durrant, I Spendlove, et al.
Clinical Immunology (Orlando, Fla.)|May 30, 2008
T-cell responses in osteosarcoma patients vaccinated with an anti-idiotypic antibody, 105AD7, mimicking CD55G J Ullenhag, I Spendlove, N F S Watson, et al.
The Journal of Pathology|November 1, 1992
Production and characterization of a polyclonal antibody to the c-erbB-3 protein: examination of c-erbB-3 protein expression in adenocarcinomasD N Poller, I Spendlove, C Baker, et al.
Cancer Immunology, Immunotherapy : CII|June 18, 2003
Enhanced expression of the complement regulatory protein CD55 predicts a poor prognosis in colorectal cancer patientsL G Durrant, M A Chapman, D J Buckley, et al.
Molecular Pathology : MP|July 13, 2000
Characterisation of a mouse monoclonal anti-idiotype reactive with a V region sequence commonly used by human immunoglobulinsJ E McElveen, P B Furtado, S J Smith, et al.
Pageof 3